KJ-TFC-004 Drug-drug Interaction Study

NCT02967614 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Kukje Pharma